Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies
Immunogenic cell death (ICD) elicited by cancer therapy reshapes the tumor immune microenvironment. A long-term adaptative immune response can be initiated by modulating cell death by therapeutic approaches. Here, the major hallmarks of ICD, endoplasmic reticulum (ER) stress, and damage-associated m...
Main Authors: | Ángela-Patricia Hernández, Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Halin Bareke, Enrique Montalvillo, Rafael Góngora, Manuel Fuentes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2821 |
Similar Items
-
Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
by: Vanessa Acebes-Fernández, et al.
Published: (2020-06-01) -
Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma
by: Megan Johnstone, et al.
Published: (2022-08-01) -
Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy
by: Elena Catanzaro, et al.
Published: (2022-06-01) -
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
by: Zahra Asadzadeh, et al.
Published: (2020-04-01) -
Immunogenic Cell Death Induction by Ionizing Radiation
by: Mengqin Zhu, et al.
Published: (2021-08-01)